Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovica Aliberti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Minerva Obstetrics and Gynecology|December 15, 2021
Bone health in adolescenceMaria R Ambrosio, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine|July 28, 2023
Long-term low-dose tolvaptan efficacy and safety in SIADHMarta Bondanelli, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine|July 30, 2025
Serum-negative chronic thyroiditis: an insidious nosographic entity cause of hypothyroidism, goiter and difficult thyroidectomyGiuseppe Santangelo, Elvira La Mantia, Immacolata Cozzolino, et al.
Endocrine|September 19, 2020
Hypeprolactinemia: still an insidious diagnosisLudovica Aliberti, Irene Gagliardi, Romolo M Dorizzi, et al.
British Journal of Haematology|June 30, 2022
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuriaLudovica Aliberti, Irene Gagliardi, Maria Rita Gamberini, et al.
Radiology Case Reports|June 25, 2021
Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case reportFabio Pellegrino, Francesca Scabbia, Annalisa Merlo, et al.
Frontiers in Endocrinology|December 5, 2022
Pituitary apoplexy and COVID-19 vaccination: a case report and literature reviewLudovica Aliberti, Irene Gagliardi, Roberta Rizzo, et al.
Frontiers in Neuroscience|September 25, 2023
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)Chiara Pane, Alberto Maria Marra, Ludovica Aliberti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Minerva Obstetrics and Gynecology|December 15, 2021
Bone health in adolescenceMaria R Ambrosio, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine|July 28, 2023
Long-term low-dose tolvaptan efficacy and safety in SIADHMarta Bondanelli, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine|July 30, 2025
Serum-negative chronic thyroiditis: an insidious nosographic entity cause of hypothyroidism, goiter and difficult thyroidectomyGiuseppe Santangelo, Elvira La Mantia, Immacolata Cozzolino, et al.
Endocrine|September 19, 2020
Hypeprolactinemia: still an insidious diagnosisLudovica Aliberti, Irene Gagliardi, Romolo M Dorizzi, et al.
British Journal of Haematology|June 30, 2022
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuriaLudovica Aliberti, Irene Gagliardi, Maria Rita Gamberini, et al.
Radiology Case Reports|June 25, 2021
Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case reportFabio Pellegrino, Francesca Scabbia, Annalisa Merlo, et al.
Frontiers in Endocrinology|December 5, 2022
Pituitary apoplexy and COVID-19 vaccination: a case report and literature reviewLudovica Aliberti, Irene Gagliardi, Roberta Rizzo, et al.
Frontiers in Neuroscience|September 25, 2023
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)Chiara Pane, Alberto Maria Marra, Ludovica Aliberti, et al.
Pageof 1